Toxoplasma-proximal and distal control by GBPs in human macrophages

Pathog Dis. 2022 Jan 7;79(9):ftab058. doi: 10.1093/femspd/ftab058.

Abstract

Human guanylate binding proteins (GBPs) are key players of interferon-gamma (IFNγ)-induced cell intrinsic defense mechanisms targeting intracellular pathogens. In this study, we combine the well-established Toxoplasmagondii infection model with three in vitro macrophage culture systems to delineate the contribution of individual GBP family members to control this apicomplexan parasite. Use of high-throughput imaging assays and genome engineering allowed us to define a role for GBP1, 2 and 5 in parasite infection control. While GBP1 performs a pathogen-proximal, parasiticidal and growth-restricting function through accumulation at the parasitophorous vacuole of intracellular Toxoplasma, GBP2 and GBP5 perform a pathogen-distal, growth-restricting role. We further find that mutants of the GTPase or isoprenylation site of GBP1/2/5 affect their normal function in Toxoplasma control by leading to mis-localization of the proteins.

Keywords: Toxoplasma gondii; GBP1; guanylate binding protein; interferon; macrophage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Disease Susceptibility
  • GTP-Binding Proteins / metabolism*
  • Host-Parasite Interactions
  • Humans
  • Macrophages / immunology*
  • Macrophages / metabolism*
  • Macrophages / parasitology*
  • Toxoplasma / immunology*
  • Toxoplasmosis / immunology*
  • Toxoplasmosis / metabolism*
  • Toxoplasmosis / parasitology*

Substances

  • Biomarkers
  • GTP-Binding Proteins